These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34635150)

  • 1. Congenital hemophilia A with low activity of factor XII: a case report and literature review.
    Lei B; Liang C; Feng H
    Ital J Pediatr; 2021 Oct; 47(1):204. PubMed ID: 34635150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy].
    Kageyama T; Mizuguchi M; Okamoto Y; Yagi H; Kagawa K; Shibata H; Ozaki S
    Rinsho Ketsueki; 2023; 64(3):198-202. PubMed ID: 37019673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis and management of congenital hemophilia.
    Carcao MD
    Semin Thromb Hemost; 2012 Oct; 38(7):727-34. PubMed ID: 23011791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Stage Factor VIII Assays.
    Duncan E; Rodgers S
    Methods Mol Biol; 2017; 1646():247-263. PubMed ID: 28804834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
    Sherief LM; Gaber OA; Youssef HM; Sherbiny HS; Mokhtar WA; Ali AAA; Kamal NM; Abdel Maksoud YH
    Ital J Pediatr; 2020 Sep; 46(1):129. PubMed ID: 32928254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Refractory acquired hemophilia A in which factor VIII inhibitor was not detected at onset and thereafter deteriorated after total hip replacement arthroplasty].
    Tanaka H; Yokota A; Onoda M; Uehara T; Terano T
    Rinsho Ketsueki; 2008 Nov; 49(11):1548-51. PubMed ID: 19047786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A.
    Collins PW; Blanchette VS; Fischer K; Björkman S; Oh M; Fritsch S; Schroth P; Spotts G; Astermark J; Ewenstein B;
    J Thromb Haemost; 2009 Mar; 7(3):413-20. PubMed ID: 19143924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
    Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
    Rodgers S; Duncan E
    Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.
    Young G; Mahlangu J; Kulkarni R; Nolan B; Liesner R; Pasi J; Barnes C; Neelakantan S; Gambino G; Cristiano LM; Pierce GF; Allen G
    J Thromb Haemost; 2015 Jun; 13(6):967-77. PubMed ID: 25912075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.
    Saito T; Mukae J; Nakamura Y; Inaba H; Nogami K; Koyama T; Fukutake K; Yamamoto K
    Intern Med; 2017; 56(13):1719-1723. PubMed ID: 28674365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and management of hemophilia].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic treatment with low- and intermediate-dose factor VIII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis].
    Zhuang JM; Sun XY; Zhou X; Liu ZQ; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):496-501. PubMed ID: 29735454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
    Duncan EM; Rodgers SE; McRae SJ
    Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Analysis of Intracranial Hemorrhage in Children with Hemophilia A.
    Hu Q; Zhang A; Liu AG; Wang SM; Wang YQ; Zhang LQ
    Curr Med Sci; 2018 Oct; 38(5):875-879. PubMed ID: 30341523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII therapy for hemophilia A: current and future issues.
    Aledort L; Ljung R; Mann K; Pipe S
    Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in the diagnosis of hemophilia severity: What to do?
    van Moort I; Joosten M; de Maat MP; Leebeek FW; Cnossen MH
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27734582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.